- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chengda Pharmaceuticals Co Ltd (301201)
Chengda Pharmaceuticals Co Ltd stock price live, this page displays SZ 301201 stock exchange data. View the 301201 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chengda Pharmaceuticals Co Ltd real time stock price chart below.
What Is the Chengda Pharmaceuticals Co Ltd Stock Price Today?
The Chengda Pharmaceuticals Co Ltd stock price today is 34.59.
What Is the Stock Symbol for Chengda Pharmaceuticals Co Ltd?
The stock symbol for Chengda Pharmaceuticals Co Ltd is "301201."
What Stock Exchange Does Chengda Pharmaceuticals Co Ltd Trade On?
Chengda Pharmaceuticals Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Chengda Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Chengda Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301201 quote. (ISIN: CNE100005766)
What Is the Chengda Pharmaceuticals Co Ltd Stock Price Today?
The Chengda Pharmaceuticals Co Ltd stock price today is 34.59.
What Is the Stock Symbol for Chengda Pharmaceuticals Co Ltd?
The stock symbol for Chengda Pharmaceuticals Co Ltd is "301201."
What Stock Exchange Does Chengda Pharmaceuticals Co Ltd Trade On?
Chengda Pharmaceuticals Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Chengda Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Chengda Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 301201 quote. (ISIN: CNE100005766)
Shenzhen
Currency in CNY
34.59
-1.75(-4.82%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.52
36.79
52 wk Range
26.38
65.03
301201 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.5236.79
52 wk Range
26.3865.03
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.55%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
301201 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 25, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
127.25M / --
Compare 301201 to Peers and Sector
Metrics to compare | 301201 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301201PeersSector | |
|---|---|---|---|---|
P/E Ratio | −233.4x | 18.9x | −0.4x | |
PEG Ratio | −5.24 | 0.50 | 0.00 | |
Price/Book | 2.5x | 2.3x | 2.6x | |
Price / LTM Sales | 10.9x | 2.9x | 3.1x | |
Upside (Analyst Target) | - | 48.4% | 48.1% | |
Fair Value Upside | Unlock | 9.4% | 6.3% | Unlock |
ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, blood and hematopoietic organs, musculoskeletal system, digestive tract and metabolism, antineoplastic and immunomodulators; and pharmaceutical intermediates comprising drug intermediates for blood and hematopoietic organs, drug intermediates in digestive tract and metabolism, and nervous system drug intermediates. ChengDa Pharmaceuticals Co., Ltd. was founded in 1980 and is based in Jiaxing, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Chengda Pharmaceuticals (301201) Stock Price Today?
The Chengda Pharmaceuticals stock price today is 34.59 CNY.
What Stock Exchange Does Chengda Pharmaceuticals Trade On?
Chengda Pharmaceuticals is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Chengda Pharmaceuticals?
The stock symbol for Chengda Pharmaceuticals is "301201."
Does Chengda Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The Chengda Pharmaceuticals dividend yield is 0.55%.
What Is the Chengda Pharmaceuticals Market Cap?
As of today, Chengda Pharmaceuticals market cap is 5.24B CNY.
What Is Chengda Pharmaceuticals's Earnings Per Share (TTM)?
The Chengda Pharmaceuticals EPS (TTM) is -0.15.
From a Technical Analysis Perspective, Is 301201 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Chengda Pharmaceuticals Stock Split?
Chengda Pharmaceuticals has split 1 times.
How Many Employees Does Chengda Pharmaceuticals Have?
Chengda Pharmaceuticals has 659 employees.
What is the current trading status of Chengda Pharmaceuticals (301201)?
As of Aug 30, 2026, Chengda Pharmaceuticals (301201) is trading at a price of 34.59 CNY, with a previous close of 36.34 CNY. The stock has fluctuated within a day range of 34.52 CNY to 36.79 CNY, while its 52-week range spans from 26.38 CNY to 65.03 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.